chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Incredible stiffness; Pain in hips, knees, calves, and feet; Lower extremity joint pain/joint pain that lingers; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Incredible stiffness), PAIN IN EXTREMITY (Pain in hips, knees, calves, and feet) and ARTHRALGIA (Lower extremity joint pain/joint pain that lingers) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]), ESCITALOPRAM and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Incredible stiffness), PAIN IN EXTREMITY (Pain in hips, knees, calves, and feet) and ARTHRALGIA (Lower extremity joint pain/joint pain that lingers). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (Incredible stiffness), PAIN IN EXTREMITY (Pain in hips, knees, calves, and feet) and ARTHRALGIA (Lower extremity joint pain/joint pain that lingers) had resolved.            This case was linked to MOD-2022-544329, MOD-2022-544381, MOD-2022-544382 (Patient Link).
I tested positive for COVID-19 on 11/19/22. I had fatigue, fever, shortness of breath, and a loss of appetite. I contacted a doctor but was not prescribed medication. I just took TYLENOL for my fever and that was it. I ended up having to be hospitalized because I was having trouble breathing and couldn't sleep on my back. I had to sit up to sleep. I had to stay there for about 3 weeks.
Heart palpitations, muscle spasms/twitching, anxiety, numbness/tingling, and elevated platelets
-Swelling, redness right thigh -RN -increased fussiness -RN -tx interventions: administer Tylenol q4'; recommended in-office evaluation, RN
Day one - within 4 hours facial swelling, ear itchiness, throat itchiness, not severe enough for ER but benadryl used.  Day eight -  Thru 11 swelling and red raised hot rash at injection site, flu like symptoms, gastro issues
Initial unsolicited report received from pharmacist on 14 October 2016. This case involves 66- year-old female patient who was vaccinated with dose of Fluzone HD (Batch number: UI666AA, expiration date 13 April 2017, dose and route of administration was not reported) in left deltoid on an 14 October 2016. Patient Illness at time of vaccination reported as none and pre-existing physician diagnosed allergies, birth defects and medical conditions include latex and almond allergy and hypertension. Concomitant medication was reported as none. On 14 October 2016, 20 minutes following vaccination patient had tingling in her left middle finger lasting 10 minutes, now finger was slightly numb. Lab data reported as none. Corrective treatment was not reported. On 14 October 2016 patient recovered from tingling in her left middle finger. Outcome of other event was reported as unknown. List of documents held by sender: none.
3/19/07 child presented with vomiting and diarrhea for 3 days. Day 3 fever and respiratory-Dr. visit with treatment of Albuterol and Amoxicilin. Then on the 26th Dr gave Zithromax. 3/27/07 presented with approx 30 raised spots-pin point-?blistery. No drainage. 3/30/07 Dr visit-Dr reported "if the puss" they are chicken pox. They did not.
Severe diarrhea, vomiting, dry-heaving, neck pain, headache, fever, chills, severe shakes, nausea
Pt recv vax on 3/15/99; on same day pt exp fussiness, screaming, dec appetite
On about 2/28/2023, I began to feel weak and feverish. I may have had a bit of a sore throat, but I'm not sure. I took a home antigen test on 3/2/2023, and the result was positive. After I tested positive, I isolated myself primarily in my bedroom. The symptoms were pretty mild, and I felt sort of like I had a bad cold, but I decided to stay in the bedroom as much as possible, as I did not want to expose my wife to the virus too much. I called my doctor and informed him of the situation, and he basically told me that I would have to wait it out. He asked me if I wanted Paxlovid, but I didn't feel sick enough to take it, so I didn't. About seven days after I tested positive, I tested myself again and got a negative response. After I made my recovery, I would often feel a little fatigued in the evenings. My temperature was also usually half a degree higher than my baseline. When I told my doctor about it, he wondered if I had long COVID-19. On 5/9/2023, I underwent a lipid panel, a urinalysis, a comprehensive metabolic panel, erythrocyte sedimentation rate, complete blood count, TSH, and C-reactive protein. They were all normal, except my TSH level was 5.92.
Myocarditis with elevated cardiac biomarkers and decreased EF.  Patient had chest pain on admission along with nausea, vomiting and diarrhea.
I developed a rash on my back approximately 35 hours after receiving my second dose of the Moderna Covid Vaccine.  It is very red, itchy, and painful.  After starting on my back, it has spread to my sides and chest as well (it did this around 12 hours after the rash started on my back).  Sought treatment at Urgent Care, and was told it may be a reaction to a soap or laundry detergent (which is the same I have been using for a long time), or some kind of minor reaction to 2nd vaccine, given the timing.
Besides having a sore arm the major problem I'm experiencing is vertigo like. I have this feeling 24x7. It's worse in the mornings and constant all day.
4/21/04: developed eye infection and has been seen by 2-3 doctors for treatment of infection. At present, mom states it is resolved.  Took 6 weeks of eye meds. (All info per mother).
achy; headache; lethargy; This is a spontaneous report from a contactable consumer.   A 69-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation.  Medical history included High blood pressure.  The patient's concomitant medications were not reported.  After the second dose, the patient felt achy, had a headache and lethargy. The patient has normal temperature. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a pharmacist refers to a female patient, also a registered nurse, of unknown age with herpes simplex. On 05-NOV-2013 the patient was vaccinated with ZOSTAVAX (lot number J006150/ 08/30/2014) dose 1, 0.65 ml, subcutaneous. No other suspect therapy was reported. Concomitant therapies included VALTREX. The pharmacist reported that the patient reported that on 06-NOV-2013 she began developing a rash on an unspecified location on her body, and she believes that she has shingles. The patient called to provide follow up information. She stated that since she received the ZOSTAVAX she has experienced a headache. She stated that after receiving the ZOSTAVAX she developed a wheal on her upper arm that is red, hot, itchy, painful and with a slight demarcation. She states that she has a history of herpes simplex and that this lesion feels like a herpes simplex lesion. She stated that she was not taking her VALTREX at the time of the ZOSTAVAX injection, and has not taken any doses since she got the ZOSTAVAX. She stated that she has not seen her physician, but she has emailed her physician with a picture of the lesion. No treatment information was reported. The outcome of shingles, developed a wheal on her upper arm that is red, hot, itchy, painful and with a slight demarcation, headache and lesion feels like a herpes simplex lesion is unknown. The reporters relatedness of shingles, developed a wheal on her upper arm that is red, hot, itchy, painful and with a slight demarcation, headache and lesion feels like a herpes simplex lesion to ZOSTAVAX is unknown. Additional information has been requested.
patient developed pain and swelling in the shoulder that later spread all the way across his back to his other shoulder. It has improved, but it still feels like he has a tight muscle in the shoulder what was injected. i was the one to give his vaccine, and i know for sure that i gave it in the most central, thickest region of the medial deltoid and did not give it too high. I told him that as well, and he confirmed that i gave it in the muscle. he said a long time ago, he received a shot that was too high, and he knew i didn't give it too high.
Information has been received from a physician concerning a female who was vaccinated with a "single dose" of Zostavax (Oka/Merck).  On an unspecified date, post vaccination, the patient experienced redness and swelling at the injection site.  It later developed into a hard mass under her arm away from the injection site.  The patient had surgery to remove the mass but did not allow the mass to be fully removed and she now suffers from nerve damage.  At the time of the report the patient's status was not recovered.  A product quality complaint was not involved.  The adverse events reported were considered to be Other Medically Important Events (OME) by the reporter.  Additional information has been requested.
Woke up at 1:00 am in a sweat, sore and achy. Had a headache that got worse as the day went on. This headache turned into a migraine. I was so sore I couldn?t get out of bed. It got worse throughout the day. I had a fever and chills. At 48 hours my head was still in a fog, eyes wouldn?t focus, dizzy and hurt especially when I coughed or sneezed. Arm, armpit were swollen and sore. At 6o hours my head was better but still sore. I was told not to take medication and the ?ride it out.?
pt recvd vax; c/o soreness lt arm; bruised area red & hot, painful to move; no swelling; red area became bluish-black area, still painful;apap & cold compress used;
Electric shock through my whole body. I have had nerve pain in my arms and extreme fatigue since then. Every day I feel like I'm coming down with the flu.
Fever, 103 degrees. Vomiting the following morning at 9 AM.
Expected arm soreness in the 2 days following vaccination, subsided. Then, 10 days following vaccination, employee experienced intermittent tenderness and difficulty with horizontal elevation of arm. Which has not resolved.
Sever arm pain had difficulty sleeping due to this.  No redness at injection, difficulty moving arm following day.  Pt tried OTC Tylenol which did not relieve pain.  Advised to apply ice packs and to try Ibuprofen for pain and Benadryl to help with sleep.  Also reported feeling a bit dizzy and having chills and throat pain.  Advised to continue to treat symptoms.
Shortness of breath and chest pains immediately after administration. Transported to hospital. Outcome unknown.
Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.
This spontaneous report as received from a Licensed vocational nurse refers to a patient of unknown age and gender. On 20-SPR-2016, the patient was vaccinated with an improperly stored dose of VAQTA (lot # M003011 exp date 15-NOV-2017) (dose and route not reported). The vaccine's temperature excursion was 47.5 degrees F for 30 minutes. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
pt recv vax 7OCT97 & on 23OCT97 pt exp serum sickness like rxn;pt required f/u w/a MD & was treated (NOS) for the event;pt condition is currently ongoing;
Inadvertanly given Pfizer bivalent booster.  Previuosly vaccinated with primary series of pfizer but was waiting for bivalent booster. Vaccine counseling done.
Patient: Male, 58, active distance runner (winter maintenance mode 3-5 5K treadmill runs per week) registered for two 100-mile races in summer of 2022 ? Currently stopped running due to pain in shoulders and hips increasing after running.   Nighttime Pain level: 8 of 10 in left shoulder; 7 of 10 in right shoulder; 4 of 10 in hips. Significant interruption of sleep with numerous wakeups, painful to reposition or roll over and inability to find pain free comfort while in bed.  Daytime Pain level: (with use)3-4 in hips and 4-5 in shoulders. Able to complete most tasks required for work. Hip pain has gotten worse in the last two days.   Impacted tasks ? stiffness and pain donning shirts and jackets, rising from bed and seated positions after sedentary periods, extending arms and raising arms above shoulder level. Pain and stiffness has continued to escalate in hips. Work is significantly impacted due to sleep deprivation-caused fatigue and brain fog.   In the last several days, I have been losing my battle to remain upbeat against the constant pain and have been struggling with depression.  Onset:  Left shoulder achiness post Covid booster Dec. 7. Soreness began in the right shoulder approximately 3-5 days after booster. Sleep disturbance due to increasing pain began after the third week of Dec. Sleep became increasingly difficult due to high level of pain in both shoulders. The left shoulder is an 8 of 10; the right is 7 of 10.  Hip pain came on gradually around Jan 1, making it increasingly difficult and painful to get out of bed and rise from seated positions after extended periods of sitting. Pain is 4 of 10. Pain is at its highest level at sleep, causing numerous wakeups and repositioning.   Visit to Urgent Care Friday January 28th: Numerous blood tests were ordered by Dr. in preparation for meeting with Dr. on Thursday Feb. 3rd. Tests results returned over the weekend.    Medications: Taking Ibuprofen has been ineffective.
Dexterity issues in both hands; Tingling in fingers and forearms; Minor balance issues; Sensation in bony part of nose; General fatigue; Malaise; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 26Apr2021 at 13:00 (at the age of 51-years-old) as a single dose and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ?W0161) via an unspecified route of administration in the right arm on 18May2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history.  The patient had no known allergy other than possibly lobster (shellfish allergy). Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included finasteride (MANUFACTURER UNKNOWN) and multivitamins; all for unknown indication from unknown dates and unknow if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021, the patient experienced dexterity issues in both hands, tingling in fingers and forearms, minor balance issues, sensation in bony part of nose, general fatigue and malaise. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events and included  examination and rule out of vertigo by ENT on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of  dexterity issues in both hands, tingling in fingers and forearms, minor balance issues, sensation in bony part of nose, general fatigue and malaise were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Day 1: Severe headaches, severe dizziness  Day 3: heart palpations, continued h/a Day 6: rash at injection site, continued palpations Day 7: baseball sized rash at injection site, right arm/chest swelling, palpations  Day8: severe dizziness, headaches,  and continuing rash Day 10: acute rash face and neck, continued palpations
some lower leg cramping; several severe morning charley horses; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received BNT162b2 (BNT162B2), on 12Mar2021 as dose 1, single (Lot number: EN6203) at the age of 69 years, in arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: MUSCLE SPASMS (non-serious) with onset Mar2021, outcome "unknown", described as "several severe morning charley horses"; MUSCLE SPASMS (non-serious) with onset Apr2021, outcome "unknown", described as "some lower leg cramping". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of muscle spasms.  Additional information: The patient had occasional left arm cramping after small amount of activity. Leg cramping was worse at night but acetaminophen, and resting and applying heat helps.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Jul2022 at 09:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 33 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Negative; Negative; Negative; Negative; Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient did not received other medication in 2 weeks. Covid symptoms and testing positive after 5 negatives. The patient received Covid-19 treatment included PAXLOVID from 13Sep2022 to 17Sep2022. The patient had no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from an 81 year old female consumer with no known history or allergies who on 06, Mar 2007 was vaccinated SC with a 0.65 ml dose of zoster vaccine live (Oka/Merck). Concomitant therapy included atorvastation calcium (LIPITOR), and alendronate sodium (MSD). On 15, Mar 2007 the patient developed shingles. Unspecified medical attention was sought. No laboratory test were performed. At the time of the report the patient was recovering. No further information is available.
Pt was seen in office 1/27/03 for rash, was diagnosed at this time with chickenpox. He had the varicella immunization on 1/6/03.
Patient is brought on 6/30/2016 in by mom complaining of rash on left arm times 1 day. Patient received BEXSERO vaccine on left deltoid 7 days ago and was  fine until 6/29/2016. The rash is itchy and confluent on 6/30/2016. No other exposure, no fever, cough, runny nose, trauma. Diphenhydramine HCl (BENADRYL Allergy) 25 MG Oral Tablet Sig: 1 - 1 1/2 tab po Q 6 hours prn.
Rash all over her body a few days after first and second dose; This spontaneous case was reported by a patient and describes the occurrence of RASH (Rash all over her body a few days after first and second dose) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Rash all over her body a few days after first and second dose). At the time of the report, RASH (Rash all over her body a few days after first and second dose) outcome was unknown.            No concomitant medications were reported.  The patient stopped and did not receive any more COVID-19 vaccines.  No treatment medications were reported.   This case was linked to MOD-2022-670284.   Reporter did not allow further contact
82 year old female previously vaccinated against Covid-19 with the Moderna vaccine on 12/30/20 and 1/27/21, admitted to the hospital on 7/9/2021 with severe Covid-19 pneumonia.
THROMBOSIS OF THE CLOT; INCREASED FREQUENCY OF MIGRAINES/VERTIGO; STROKE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included vertigo, and concurrent conditions included lupus antiphospholipid syndrome, and migraine. The patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021, 1 total dose for prophylactic vaccination. Concomitant medications included Xarelto (rivaroxaban) for lupus antiphospholipid syndrome.  On APR-2021, the patient developed thrombosis of the clot and increased frequency of migraines/vertigo (over the past month or two). On 04-JUN-2021 (3 night ago), she was diagnosed with stroke. Later, she underwent procedure for thrombosis of the clot and she was stable. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from stroke, and thrombosis of the clot, and the outcome of increased frequency of migraines/vertigo was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210617520-covid-19 vaccine ad26.cov2.s-Stroke, Thrombosis Of The Clot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Pfizer-BioNTech COVID-19 Vaccine EUA: Patient vaccinated at COVID-19 Vaccine Center. They were brought to observation area and proceeded to have hives and reddening of face, neck and injection site. BLS (EMS) treated patient on site and patient escorted out via wheelchair.
Was given suboptimal dose and patient went on a trip for 2 weeks. We were able to contact him when he came back home and his fine & we will be monitoring him weekly.
Looking back, I had a slow, intermittent pain in my right shoulder/arm region. It was nonspecific but mostly related when raising my arm while getting dressed/putting my shirt on. It became more frequent over the next month. This past week it seemed to be more classic like a "tendonitis" towards the mid-distal deltoid region.
usual adverse reactions included body aches, chills, low grade temp (below 100.0F)runny nose, head congestion. Around 8:30pm, eyes began watering and burning, migraine type pain on left side of head began. At 6am January 7, 2020 left side of face was swollen and sensitivity to light present, pressure and discomfort only on that side of face. Eye swollen and continuously watering.